Cargando…
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
BACKGROUND: The therapeutic options for patients with Multiple Sclerosis (MS) have steadily increased due to the approval of new substances that now supplement traditional first-line agents, demanding a paradigm shift in the assessment of disease activity and treatment response in clinical routine....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977700/ https://www.ncbi.nlm.nih.gov/pubmed/27502119 http://dx.doi.org/10.1186/s12883-016-0648-6 |